Get the Stockscreener App
4.97
4.08%
0.195
Endra Life Sciences Inc stock is traded at $4.97, with a volume of 7,105.
It is up +4.08% in the last 24 hours and down -11.25% over the past month.
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.
See More
Previous Close:
$4.775
Open:
$4.95
24h Volume:
7,105
Relative Volume:
0.38
Market Cap:
$7.45M
Revenue:
$357.80K
Net Income/Loss:
$-7.30M
P/E Ratio:
-0.61
EPS:
-8.148
Net Cash Flow:
$-8.01M
1W Performance:
-16.19%
1M Performance:
-11.25%
6M Performance:
-3.31%
1Y Performance:
-32.93%
1-Day Range:
$4.925
$5.14
1-Week Range:
$4.7298
$6.015
52-Week Range:
$2.96
$8.00
Endra Life Sciences Inc Stock (NDRA) Company Profile
Name
Endra Life Sciences Inc
Sector
Industry
Phone
734-335-0468
Address
3600 GREEN COURT, ANN ARBOR, MI
Compare NDRA vs TMO, DHR, NTRA, A, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
4.97 | 7.45M | 357.80K | -7.30M | -8.01M | -8.148 |
TMO
Thermo Fisher Scientific Inc
|
693.71 | 256.50B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
231.62 | 162.83B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
402.48 | 58.02B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
176.38 | 49.73B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
270.16 | 44.47B | 16.63B | 1.39B | 2.12B | 8.0674 |
Endra Life Sciences Inc Stock (NDRA) Latest News
A 10% owner holds warrants with a $0.0001 exercise price in ENDRA Life Sciences (NDRA). - Stock Titan
187,169 warrant shares are part of ASP Isotopes' stake in ENDRA Life Sciences (NDRA). - Stock Titan
ENDRA Life Sciences Amends Merger Agreement and Warrants - The Globe and Mail
Endra Life Sciences amends merger agreement and increases loan capacity - Investing.com
A three-class board is off the table as ENDRA Life Sciences (NDRA) revises proposed merger terms. - Stock Titan
Director buys 15,000 shares in ASP Isotopes (ASPI), bringing his direct holdings to 675,222. - Stock Titan
Endra Life Sciences amends merger agreement and increases loan capacity - Investing.com India
Form 8K ENDRA Life Sciences Inc For: 1 October By Investing.com - Investing.com India
Form DEF 14A ENDRA Life Sciences Inc For: 28 September By Investing.com - Investing.com Nigeria
Form DEF 14A ENDRA Life Sciences Inc For: 28 September By Investing.com - Investing.com India
ENDRA Life Sciences Submits Form 425 Detailing Proposed Multi-Party Deal with Renergen and Noble Africa - kalkinemedia.com
Helium supply pitch puts ENDRA (NASDAQ: NDRA) merger plan on national TV - Stock Titan
ASP Isotopes (ASPI) COO sells shares to cover taxes - Stock Titan
South African helium venture taps ENDRA (NASDAQ: NDRA) for reverse merger listing - Stock Titan
ENDRA Life Sciences (NDRA) shares ASP Isotopes' first Capital Markets Day - Stock Titan
Endra Life Sciences Stock Price Forecast. Should You Buy NDRA? - StockInvest.us
ASP Isotopes (ASPI) COO sells 25,000 shares but keeps 2.26M - Stock Titan
ENDRA jumps 12% on surprise profit, advances Noble Africa merger with $50M raise - Dealroom
ASP Isotopes (ASPI) CEO sells shares to pay tax bill - Stock Titan
ASP Isotopes Inc. (ASPI) officer lines up stock sales from equity award - Stock Titan
ASP Isotopes (NASDAQ: ASPI) holder plans 1.44M-share sale tied to stock award taxes - Stock Titan
ASP Isotopes (NASDAQ: ASPI) holder moves to sell 50,000 shares - Stock Titan
ENDRA Life Sciences Inc. Warrants (NDRAW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
ENDRA Life Sciences Inc. Warrants (NDRAW) Peer Comparison – Compare with Others - Value Research
ENDRA Life Sciences Inc. Warrants (NDRAW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
ENDRA Life Sciences (NDRA) Slides 7.4% to $5.0 as Stock Approaches Critical Support at $4.75Call Wall - siam.in
ENDRA Life Sciences Inc. Warrants (NDRAW) Key Financial Ratios – Valuation, Profitability & More - Value Research
ENDRA Life Sciences (NDRA) Slides 7.4% to $5.0 as Stock Approaches Critical Support at $4.75Volatility Skew - dars.gov.et
ENDRA (NDRA) Results at a Glance: Reported EPS Misses Expectations for the Current Session; Latest Reaction: The Share Price Sheds 2.07% at the CloseCapex Guidance - vinanet.vn
ENDRA (NASDAQ: NDRA) weighs shift into South African helium - Stock Titan
ENDRA Life Sciences (NASDAQ: NDRA) shares ASP Isotopes helium plant update - Stock Titan
ENDRA (NDRA) Price: Moves 0.22% Lower to $4.50 on the Day; Boundary Watch: $4.27 and $4.73 Define the Nearby Reference Levels at the CloseSentiment Extreme - vinanet.vn
ENDRA Life Sciences Swings To Q2 Profit On Digital Asset Gains Ahead Of Noble Africa Merger - pulse2.com
ENDRA Life Sciences (NDRA) Holds Above Support, Edges Up 0.45% to $4.49Up Down Volume - dars.gov.et
ENDRA Life Sciences (NDRA) Holds Above Support, Edges Up 0.45% to $4.49Composite Profile - vinanet.vn
ENDRA to merge with Noble Africa, pivoting to helium in $50M-backed deal - Dealroom
ENDRA Life Sciences (Nasdaq: NDRA) shares Q2 2026 earnings update - Stock Titan
ENDRA Life Sciences Reports $159,944 Second-Quarter 2026 Net Income - Moomoo
ENDRA Life Sciences Reports $159,944 Second-Quarter 2026 Net Income - Quiver Quantitative
Crypto lifts ENDRA (NASDAQ: NDRA) to Q2 profit amid pending Noble Africa deal - Stock Titan
Endra Life Sciences reported Q2 net income $160,000 vs $1.2M last year - TipRanks
ENDRA (NDRA) Q2 2026 Cash Position Highlights Challenges Amid Un - GuruFocus
ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update - mykxlg.com
ENDRA Life Sciences posts Q2 profit on digital asset gains ahead of merger - TradingView
ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update - WBOC TV
ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update - Business Wire
NDRA Q1 2026 Earnings: Wider-Than-Expected $1.80 Per Share Loss Highlights Pre-Revenue Cost PressuresPretax Income Report - vinanet.vn
ENDRA Life Sciences (NDRA) Holds Steady at $4.47 Amid ConsolidationSector Sentiment - dars.gov.et
ENDRA Life Sciences (NDRA) Holds Steady at $4.47 Amid ConsolidationOBV Divergence - vinanet.vn
ENDRA Life Sciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Endra Life Sciences Inc Stock (NDRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.53%
1.96%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):